SecBecerra-18Nov2022-Sachs-Love-Xtandi November 18, 2022 Xavier Becerra Secretary Department of Health & Human Services Washington, DC Via Email: xavier.becerra@hhs.gov Dear Secretary Becerra: Today marks the one-year anniversary since the undersigned prostate cancer patients petitioned the Department of Health & Human Services… Continue Reading
Since the COVID 19 Pandemic began, there has been a spirited debate over patent rights, including a highly publicized 20 month debate over a proposed WTO waiver on intellectual property rights. During that time a handful of countries have taken… Continue Reading
This is a letter to Roche requesting a voluntary license to the patents on risdiplam, a treatment for Spinal Muscular Atrophy (SMA). KEI-Risdiplan-patent-license-request-8july2022 This was the August 5, 2022 response from Roche. Roche-Response-to-Risdiplam-license-request–5Aug2022 KEI wrote to Roche again on February… Continue Reading
Updated Friday, 17 June 2022, 11:30 AM Geneva time. Early Friday morning, 17 June 2022, the WTO’s 12th Ministerial Conference (chaired by Timur Suleymenov, Kazakshstan), adopted a Ministerial Decision on the TRIPS Agreement (WT/MIN(22)/W/15/Rev.2). The text can be found here.… Continue Reading
28 questions for broadcast treaty May 12, 2022 Term of protection 1. The 1971 Convention for the Protection of Producers of Phonograms Against Unauthorized Duplication of Their Phonograms and The 1974 Brussels Convention Relating to the Distribution of Programme-Carrying Signals… Continue Reading
These were my notes from the KEI intervention on Tuesday, May 10, 2022, at WIPO SCCR 42, on the proposed WIPO broadcasting treaty. This is essentially a related rights treaty, and goes far beyond the control of signal piracy. And… Continue Reading
On March 18, 2022, Pfizer filed a 45 page opposition to the KEI application for a compulsory license on Paxlovid patents in the Dominican Republican. This is the Pfizer filing, and KEI’s unofficial translation. Pfizer-opposition-DR-CL-18March2022.pdf Translation-Pfizer-opposition-KEI-CL-Paxlovid-18march2022.pdf The December 3, 2021… Continue Reading
See also the following essays in Medium: The proposed WTO agreement on intellectual property and COVID 19 vaccines should not require that authorizations of non-voluntary use of patents list all patents covered, Medium, March 17, 2022. The Quad WTO proposal… Continue Reading